These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30881611)

  • 1. Prospective treatment of Parkinson's disease by a siRNA-LDH nanoconjugate.
    Acharya R; Chakraborty M; Chakraborty J
    Medchemcomm; 2019 Feb; 10(2):227-233. PubMed ID: 30881611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of layered double hydroxide nanoparticle-mediated delivery of siRNA is determined by nucleotide sequence.
    Wong Y; Cooper HM; Zhang K; Chen M; Bartlett P; Xu ZP
    J Colloid Interface Sci; 2012 Mar; 369(1):453-9. PubMed ID: 22226499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of SIAH1 in SH-SY5Y affects α-synuclein degradation pathway.
    Xu J; Zhang XZ; Zhang YJ; Li XM; Cai ZL; Li XM
    Int J Clin Exp Pathol; 2015; 8(10):12885-92. PubMed ID: 26722480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MgAl- Layered Double Hydroxide Nanoparticles for controlled release of Salicylate.
    Mondal S; Dasgupta S; Maji K
    Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():557-564. PubMed ID: 27524054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's Disease.
    Helmschrodt C; Höbel S; Schöniger S; Bauer A; Bonicelli J; Gringmuth M; Fietz SA; Aigner A; Richter A; Richter F
    Mol Ther Nucleic Acids; 2017 Dec; 9():57-68. PubMed ID: 29246324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-212 Attenuates MPP⁺-Induced Neuronal Damage by Targeting KLF4 in SH-SY5Y Cells.
    Song Y; Liu Y; Chen X
    Yonsei Med J; 2018 May; 59(3):416-424. PubMed ID: 29611404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery system for berberine chloride based on the nanocarrier ZnAl-layered double hydroxide: Physicochemical characterization, release behavior and evaluation of anti-bacterial potential.
    Djebbi MA; Elabed A; Bouaziz Z; Sadiki M; Elabed S; Namour P; Jaffrezic-Renault N; Amara ABH
    Int J Pharm; 2016 Dec; 515(1-2):422-430. PubMed ID: 27771486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers.
    Zheng W; Yin T; Chen Q; Qin X; Huang X; Zhao S; Xu T; Chen L; Liu J
    Acta Biomater; 2016 Feb; 31():197-210. PubMed ID: 26612416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.
    Chorfa A; Bétemps D; Morignat E; Lazizzera C; Hogeveen K; Andrieu T; Baron T
    Toxicol Sci; 2013 Jun; 133(2):289-97. PubMed ID: 23535362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced colloidal stability and protein resistance of layered double hydroxide nanoparticles with phosphonic acid-terminated PEG coating for drug delivery.
    Cao Z; Adnan NNM; Wang G; Rawal A; Shi B; Liu R; Liang K; Zhao L; Gooding JJ; Boyer C; Gu Z
    J Colloid Interface Sci; 2018 Jul; 521():242-251. PubMed ID: 29574343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein.
    Ham A; Kim DW; Kim KH; Lee SJ; Oh KB; Shin J; Mar W
    Brain Res; 2013 Aug; 1524():54-61. PubMed ID: 23751361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate-chitosan coated layered double hydroxide nanocomposites for enhanced oral vaccine delivery.
    Yu X; Wen T; Cao P; Shan L; Li L
    J Colloid Interface Sci; 2019 Nov; 556():258-265. PubMed ID: 31450020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanostructure controlled sustained delivery of human growth hormone using injectable, biodegradable, pH/temperature responsive nanobiohybrid hydrogel.
    Singh NK; Nguyen QV; Kim BS; Lee DS
    Nanoscale; 2015 Feb; 7(7):3043-54. PubMed ID: 25603888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular drug delivery of layered double hydroxide nanoparticles.
    Oh JM; Park CB; Choy JH
    J Nanosci Nanotechnol; 2011 Feb; 11(2):1632-5. PubMed ID: 21456254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriol inhibits α-synuclein aggregation in SH-SY5Y neuroblastoma cells by a Calbindin-D28k-dependent mechanism.
    Rcom-H'cheo-Gauthier AN; Meedeniya AC; Pountney DL
    J Neurochem; 2017 Apr; 141(2):263-274. PubMed ID: 28164279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
    Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
    Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
    Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
    Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells.
    Yshii LM; Denadai-Souza A; Vasconcelos AR; Avellar MC; Scavone C
    J Neuroinflammation; 2015 Oct; 12():193. PubMed ID: 26502720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA NORAD regulates MPP+-induced Parkinson's disease model cells.
    Song Q; Geng Y; Li Y; Wang L; Qin J
    J Chem Neuroanat; 2019 Nov; 101():101668. PubMed ID: 31421205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.